InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（11 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
11
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Lew Jennifer, 首席财务官. Insider active across 2 companies, notably Annexon, Inc.. In total, 20 reports have been recorded. Breakdown: 0 buy · 11 sells. Total volume traded: €116k. History available since 27 May 2021. The latest transaction was disclosed on 2 March 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Lew Jennifer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报20 总计
5,565 股@ US$5.4216.1% 占其流量Common StockSEC:0001465994-26-000003:0
62,500 股0Common StockSEC:0001465994-26-000002:0
7,851 股@ US$5.1121.2% 占其流量Common StockSEC:0001465994-26-000001:0
1,117 股@ US$2.582.5% 占其流量Common StockSEC:0001415889-25-019837:0
44,963 股0Common StockSEC:0001415889-25-006193:0
6,912 股@ US$2.9213.6% 占其流量Common StockSEC:0001415889-25-004886:0
1,786 股@ US$2.983.6% 占其流量Common StockSEC:0001415889-25-004433:0
1,104 股@ US$6.034.3% 占其流量Common StockSEC:0001415889-24-019678:0
39,000 股0Common StockSEC:0001415889-24-004623:0
1,809 股@ US$5.546.6% 占其流量Common StockSEC:0001415889-24-003855:0
1,057 股@ US$3.83612.6% 占其流量Common StockSEC:0001209191-24-002072:0
18,975 股0Common StockSEC:0001567619-23-003424:0
1,742 股@ US$6.30817.3% 占其流量Common StockSEC:0001567619-23-003094:0
9,375 股0Common StockSEC:0001567619-22-013991:0
12,500 股0Common StockSEC:0001567619-22-004612:0
3,500 股@ US$7.488513.9% 占其流量Common StockSEC:0001567619-21-017165:0
3,500 股@ US$7.488513.5% 占其流量Common StockSEC:0001567619-21-011453:0
5,242 股Common StockSEC:0001209191-16-090065:0
4,442 股Common StockSEC:0001209191-16-090065:1
800 股Common StockSEC:0001209191-16-090065:2
20 条申报中的 20 条
About Lew Jennifer
Lew Jennifer is Directeur Financier. She has 20 filings in total, and across the sampled recent filings from 2016-01-06 to 2026-03-04, the reported sell amount is EUR 115700 and the buy amount is EUR 0, with the dominant transaction nature indicated as Cession. Her recent filings concern Annexon, Inc. and ADURO BIOTECH, INC., with several sales at Annexon, Inc.
